目的 分析我国社会药房自有品牌的发展现状及以后的发展趋势。方法 首先对国外社会药房自有品牌发展进行介绍,然后对我国社会药房自由品牌的发展现状进行深入分析和未来发展展望。结果与结论 由于我国目前的药品注册审批制度和医药零售行业的发展现状等因素的制约,我国社会药房自有品牌的发展处于初步的探索阶段,目前只有贴牌加工这一种方式,但是待条件成熟社会药房自有品牌药品将具有广阔的发展前景。
Abstract
OBJECTIVE To find out China's current status of private label drugs in community pharmacy and predict their future developments.METHODS Firstly, A introduction of the development of foreign private label drugs in community pharmacy were given birth by us. Then a thorough analysis of the current status of China's private label drugs and work out the predictions of their future development were carried by us.RESULTS AND CONCLUSION Due to China's registration and approval system of drugs and current status of pharmaceutical retail industry, the private label drugs of community pharmacy can be only conducted by OEM. And they are in the exploratory phase, which private label drugs can only be manufactured by OEM. But the private label drugs have great prospects for development when the conditions are mature.
关键词
社会药房 /
自有品牌 /
自有品牌药品
{{custom_keyword}} /
Key words
community pharmacy /
private brand /
private label drug
{{custom_keyword}} /
中图分类号:
R952
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Private Label Manufacturers Association(PLMA)[EB/OL]. 2011,http://plma.com.[2] ZHAO F. The Construction and Development of the Self-Brand of Chain Pharmacy Stores in Chain[D]. Wuhan: Wuhan University of Technology, 2007.[3] WANG C,WANG Z Y. The Development Status of US Retail Pharmacy Chains[J]. Int Bus Technol(国际商业技术), 2007,1: 66-69.[4] MA X X. Study on the private brand strategy of Chinese retail enterprise--The analysis of Watsons [D]. Beijing: University of international Business and Economics, 2006.[5] 2012-2016 China pharmaceutical industry investment analysis and Forecast Report[R]. Global Analysis Network, 2012.1.[6] HU F. How to ease the pharmaceutical industry overcapacity [N]. China Pharm News(中国医药报), 2008-06-12 (B01).[7] ZENG Y, LI Y, ZHANG X Y.Hospital pharmacists involving in community pharmacy services[J].Pharmacy Today(今日药学),2009,19(1):52-55.[8] ZHAO F, LIU X P.Strategy analysis on Chinese drug retailers implemented its private brand[J]. Chin Med Rep(中国医药导报),2009, 4(25):155-158.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}